Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable
Zachary S. Zumsteg, Daniel E. Spratt, Timothy J. Daskivich, Mourad Tighiouart, Michael Luu, Joseph P. Rodgers, Howard M. Sandler
Abstract
This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.
Topics & Concepts
Androgen deprivation therapyProstate cancerMedicineRadiation therapyOncologyRandomized controlled trialAndrogenInternal medicineProstateCancerHormoneProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchHealth Systems, Economic Evaluations, Quality of Life